|
Volumn 29, Issue SUPPL. 1, 1999, Pages 89-90
|
For how long should the treatment with vitamin K antagonists be maintained?
|
Author keywords
Thromboembolism; Thromboprophylaxis; Venous; Vitamin K antagonists
|
Indexed keywords
ANTIVITAMIN K;
CYANOCOBALAMIN;
FOLIC ACID;
ANTICOAGULANT THERAPY;
BLOOD TOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DEEP VEIN THROMBOSIS;
HUMAN;
HYPERHOMOCYSTEINEMIA;
LUNG EMBOLISM;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RISK;
THROMBOEMBOLISM;
|
EID: 0033387560
PISSN: 03010147
EISSN: None
Source Type: Journal
DOI: 10.1159/000054121 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|